CClinicalTrials.gg
CompletedNCT01595971RESPIRANETUpdated May 15, 2017

Distance Education Versus Usual Care Qualification in Asthma Care

An interventional study of Continuing education and usual care in Asthma, sponsored by Hospital de Clinicas de Porto Alegre. Completed at 1 site in Brazil. Open to participants aged 5 Years to 45 Years. Per ClinicalTrials.gov, last updated 2017-05-15.

Sponsored by Hospital de Clinicas de Porto Alegre · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Aug 2010, registered May 2012).
Phase
Not applicable
Study type
Interventional
Enrollment
467
Allocation
Randomized
Ages
5 Years to 45 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of multifaceted educational interventions in the care of asthma, conducted remotely over the platform TelessaúdeRS in teams of the Family Health Strategy and the consequent clinical improvement patients.

Read the detailed description

Cluster-randomized trial with follow-up of 6 months. The aim of this study is to determine whether multifaceted interventions performed at a distance for the care of asthma symptoms reduce overhead, improve asthma control and qualify the care provided to patients.

02

Conditions studied

  • Asthma

Browse trials for

Keywords

  • Asthma
  • Continuing education
  • Primary health care
03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's enrollment of 467 is above the median of 83 across 2,752 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Hospital de Clinicas de Porto Alegre is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Practice:Participate in the Telessaúde/RS. Minimal staff consisting of a general practitioner, nurse, nurse and community health agents (CHA), ability to give at least ten patients diagnosed with asthma, located in a municipality to make available for free inhaled medication (short-acting bronchodilators and corticosteroids ) for the treatment of asthma and willingness to participate in the study.
  • Patients: 5 to 45 years with a diagnosis of asthma made by a physician and register at least one consultation for asthma or an asthma-related hospitalization during the year preceding the beginning of the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with other chronic diseases with pulmonary complications such as tuberculosis, cancer and cystic fibrosis or those with severe mental illness
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
467 participants (actual)

Study arms

  • Experimental
    continuing education

    RESPIRANET is a multifaceted intervention directed at professionals of the Family Health Teams in the inner cities.Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.

    Behavioral: Continuing education

  • Placebo comparator
    Usual Care

    usual care

    Other: usual care

Interventions

  • BehavioralContinuing education

    Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.

    Also known as: RESPIRANET

  • Otherusual care

    Received the usual care provided

06

What researchers measure

Primary outcomes

  1. Symptom burden, measured as the number of self-reported asthma symptom days (ASD). ASD is based on 2 week recall.

    The definition of a symptom day includes presence of any of the four types of asthma symptoms: wheeze, cough, night time awakening ou shortness of breath. The results will be collected through the application of standardized questionnaires.

    Time frame: six months

Secondary outcomes

  1. Asthma control

    Control of asthma will be evaluated by the excessive use of relief medication in the last month.

    Time frame: 6 months

  2. Health care utilization

    Proportion of unscheduled medical visits during the follow-up

    Time frame: 6 meses

  3. Proportion of patients in use inhaled corticosteroids

    Use of inhaled corticosteroids assessed by the proportion of patients who require medication to prevent asthma symptoms that are in use of inhaled corticosteroids.

    Time frame: 6 meses

07

Study locations

1 site
  • Hospital de clínicas de Porto Alegre
    Porto Alegre, Rio grande do sul, Brazil
08

References and documents

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 15, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01595971
Lead sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Federal University of Rio Grande do Sul
Responsible party
Sponsor
First posted
May 10, 2012
Start date
Aug 12, 2010
Primary completion
Dec 16, 2011
Completion
Dec 16, 2011
Last update
May 15, 2017

Study contacts

Erno Harzheim, PHD
study chair · Federal University of Rio Grande do Sul

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion